Methimazole Market

Methimazole Market Size, Share & Industry Analysis, By Source:-(Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers.) By End-User:-(Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Methimazole market is projected to grow at a CAGR of 5.7% from 2025 to 2035, driven by the rising global prevalence of hyperthyroidism and Graves’ disease, as well as a growing preference for non-surgical treatment options. Methimazole is an antithyroid agent that inhibits the synthesis of thyroid hormones by blocking the enzyme thyroid peroxidase, thereby reducing the conversion of iodide to iodine and the formation of thyroxine (T4) and triiodothyronine (T3).

Demand for Methimazole is fueled by its established role as a first-line treatment for hyperthyroidism, especially in pediatric and pregnant patients (in select trimesters). Its long half-life, efficacy, and ease of dosing make it preferable over alternatives like propylthiouracil in many clinical settings. As awareness about thyroid health grows and screening increases, more cases of thyroid dysfunction are diagnosed early, boosting the need for effective medical therapy.

Regionally, North America currently dominates the Methimazole market due to high rates of thyroid disorders, well-established endocrinology practices, and robust healthcare access. Europe closely follows with consistent adoption across both outpatient and hospital settings. Meanwhile, Asia-Pacific is projected to witness the fastest growth due to increasing thyroid disease diagnosis rates, greater access to endocrinologists, and improved affordability in densely populated countries like China and India.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

Introduction

Overview of Methimazole
Key Applications & Industry Use Cases
Market Scope & Study Objectives

Market Overview

Global Market Size & Growth Trends (Historical & Forecast)
Market Value & Revenue Analysis
Demand-Supply Dynamics

Segmental Outlook

By Source
- Pharmaceutical Manufacturers (Branded & Generic)
- Contract Manufacturing Organizations (CMOs)
- Research-Grade Suppliers
Key End-Use Industries
- Pharmaceutical Industry.
- Hospitals & Clinics.
- Research Institutions.

Price Analysis

Current Price Trends (Per kg & Per Ton)
Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)

Production & Supply Volume

Global Production Capacity & Key Manufacturers
Production Process & Technological Developments
Raw Material Analysis

Trade Analysis (Import & Export)

Major Exporting & Importing Countries
Trade Volume & Value Statistics
Impact of Trade Regulations & Policies

Regional Analysis

North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
Rest of the World (Latin America, Middle East, and Africa)

Competitive Landscape

Top Global Manufacturers & Market Share
Company Profiles & Key Developments
Mergers, Acquisitions & Investments

Regulatory & Compliance Factors

FDA, REACH, and Other Regulatory Frameworks
Environmental & Safety Considerations
Emerging Policies Impacting Market Growth

Conclusion & Strategic Recommendations

Key Takeaways for Stakeholders
Market Entry Strategies

May 14, 2025

What is Methimazole?

Methimazole is an antithyroid medication used primarily to treat hyperthyroidism, especially Graves' disease. It works by inhibiting thyroid peroxidase, an enzyme essential for the synthesis of thyroid hormones (T3 and T4). By reducing hormone production, Methimazole helps normalize metabolic activity in patients with overactive thyroid function. It is commonly used as a first-line therapy, especially for non-pregnant adults and adolescents, and may be prescribed long-term or as a bridge to definitive treatments like radioactive iodine therapy or thyroidectomy.

What is the market growth of Methimazole?

The global Methimazole market is projected to grow at a CAGR of 4.3% from 2025 to 2035, increasing from approximately USD 370 million in 2025 to over USD 565 million by 2035. The market is driven by rising global incidence of thyroid disorders, improved screening and diagnostic rates, and greater clinical preference for non-invasive, cost-effective treatments.

What are the drivers of the Methimazole market?

Key growth drivers include the increasing prevalence of autoimmune thyroid diseases like Graves’ disease, growing global awareness about thyroid health, and a shift away from surgical interventions when manageable with medication. Methimazole's once-daily dosing, cost-effectiveness, and established efficacy make it a preferred option. Additionally, an aging population and expanding diagnostic access contribute to higher prescription rates.

Who are the key players operating in the Methimazole market?

Major pharmaceutical players include Mylan N.V. (a Viatris company), Lannett Company, Inc., Taj Pharmaceuticals, Zydus Lifesciences, and Teva Pharmaceuticals. The market is largely generic, which promotes accessibility and affordability, particularly in developing countries.

Which region will exhibit the fastest growth in the Methimazole market?

Asia-Pacific is expected to exhibit the fastest growth, led by China and India, where the prevalence of thyroid disorders is rising, and access to diagnostics is improving. North America remains the largest market due to early detection programs, endocrinologist availability, and broad insurance coverage. Europe continues to support steady growth through public health screening initiatives.

$1800/- Single User License
$3600/- Multi User License

Experienced in market research and consulting.
Seasoned professionals with diverse industry knowledge.
Proven track record in delivering valuable insights.
Tailored methodologies for unique client needs.
End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
Latest tools and tech for data collection, analysis, and visualization.
Embrace of AI and machine learning for deeper insights.
Global capabilities and extensive network.
In-depth understanding of international markets, trends, and regulations.
Dedicated to addressing specific client needs and goals.
Focus on delivering value through efficient research outcomes.

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com